Jesse I. Treu, Director at Aldeyra Therapeutics, Inc. (ALDX), sold 193,041 shares at $10.01 ($1.9M) on 2019-03-26, disclosed to the SEC on 2019-03-28.
Open-market sale of $1.9M ALDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 445 | $4K | 0.2% |
| 2 | $10.01 | 96,298 | $964K | 49.9% |
| 3 | $10.01 | 96,298 | $964K | 49.9% |
| Total | $10.01 avg | 193,041 | $1.9M | 100% |
| Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |
| EVOK | SELL | 2016-04-27 | $26K | — | Filing → |